CEIGALL NSE filing

Ceigall India Secures ₹225 Crore Bulk Drug Park Order in Himachal Pradesh

The RealCase readHigh impact Positive

Ceigall India Limited received a Letter of Award worth ₹225 crore from HPSIDC for developing a Bulk Drug Park in Una, Himachal Pradesh. The project includes infrastructure development and has an execution period of 18 months. This order strengthens the company's presence in infrastructure development across India.

Why it matters

The order value of ₹225 crore is substantial and will contribute significantly to the company's revenue and order book, impacting its financial performance.

The market read

The company has secured a significant new order, which is positive for its business growth and future prospects.

Ceigall India Limited has received a Letter of Award (LOA) from Himachal Pradesh State Industrial Development Corporation Limited (HPSIDC) for the development of a Bulk Drug Park in Una, Himachal Pradesh. The project, valued at ₹225 crore (including GST), involves formation cutting, construction of internal roads, storm water drains, a bridge, and fencing, designated as Phase I.

The contract is an item-rate contract with a performance security requirement of 3% of the contract value. The execution period for this project is 18 months. This award is considered a domestic contract and does not fall under related party transactions or involve promoter interest in the awarding entity.

Ramneek Sehgal, Managing Director of Ceigall India Limited, commented that this order is a significant milestone, reflecting the trust in the company's execution capabilities and its contribution to national and regional projects. He emphasized the company's commitment to supporting India's industrial development and economic growth, aligning with the vision of 'Viksit Bharat 2047'. The company aims to leverage its expertise to build robust infrastructure and contribute to India's economic transformation.

Filing to action

What to do with a filing like this

Ceigall India Limited filed this with the NSE as a statutory disclosure, categorised under new orders. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Ceigall India Limited. Read the original for the full detail.

View original filing